KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EBITDA: 2010-2025

Historic EBITDA for Exelixis (EXEL) over the last 16 years, with Oct 2025 value amounting to $236.5 million.

  • Exelixis' EBITDA rose 73.83% to $236.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $800.2 million, marking a year-over-year increase of 52.94%. This contributed to the annual value of $604.6 million for FY2025, which is 253.82% up from last year.
  • Latest data reveals that Exelixis reported EBITDA of $236.5 million as of Q4 2025, which was up 10.75% from $213.6 million recorded in Q3 2025.
  • Exelixis' EBITDA's 5-year high stood at $275.9 million during Q2 2024, with a 5-year trough of -$48.1 million in Q4 2022.
  • Moreover, its 3-year median value for EBITDA was $136.1 million (2024), whereas its average is $128.4 million.
  • Within the past 5 years, the most significant YoY rise in Exelixis' EBITDA was 1,906.88% (2022), while the steepest drop was 140.74% (2022).
  • Exelixis' EBITDA (Quarterly) stood at $118.0 million in 2021, then slumped by 140.74% to -$48.1 million in 2022, then skyrocketed by 270.12% to $81.8 million in 2023, then soared by 873.90% to $136.1 million in 2024, then spiked by 73.83% to $236.5 million in 2025.
  • Its EBITDA was $236.5 million in Q4 2025, compared to $213.6 million in Q3 2025 and $186.9 million in Q2 2025.